We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
632 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARIPENA aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARIPIPRAZOLE RBX aripiprazole 300 mg powder and diluent for prolonged release suspension for injection vial kit.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LANREOTIDE RBX lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LANREOTIDE RBX lanreotide (as acetate) 90 mg/0.3 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LACREO lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LANREOTIDE SUN lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LANREOTIDE SUN lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LANREOTIDE RBX lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LANREOTIDE SUN lanreotide (as acetate) 90 mg/0.3 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LACREO lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe.